Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 259860-08-7 | MDL No. : | MFCD10000894 |
Formula : | C8H5BrFN | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OIUXEDBYFWPCLF-UHFFFAOYSA-N |
M.W : | 214.03 | Pubchem ID : | 22262922 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 45.96 |
TPSA : | 15.79 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.59 cm/s |
Log Po/w (iLOGP) : | 1.9 |
Log Po/w (XLOGP3) : | 2.84 |
Log Po/w (WLOGP) : | 3.49 |
Log Po/w (MLOGP) : | 2.73 |
Log Po/w (SILICOS-IT) : | 3.62 |
Consensus Log Po/w : | 2.92 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.56 |
Solubility : | 0.0587 mg/ml ; 0.000274 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.83 |
Solubility : | 0.317 mg/ml ; 0.00148 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.42 |
Solubility : | 0.00812 mg/ml ; 0.0000379 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.74 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | With iron; acetic acid In ethanol at 90℃; | The enamine (1.89 g, 4.38 mmol) was dissolved in EtOH (35.0 ml_). To this solution Fe (4.42 g, 79.0 mmol) and acetic acid (35.0 ml_) were added and the mixture was stirred at 90 °C for overnight. The resulting mixture was filtered and concentrated. The residue was purified by column chromatography (ethyl acetate-hexane; 1 :9) to afford 6- bromo-5-fluoro-1 H-indole as a yellow solid (0.83 g, 89percent). 1H NMR (CDCI3, 400 MHz): 6.52 (m, 1 H), 7.27 (m, 1 H), 7.38 (d, J = 9.3 Hz, 1 H), 7.57 (d, J = 5.7 Hz, 1 H), 8.18 (br. s, 1 H). |
61% | With hydrazine In tetrahydrofuran; methanol at 20℃; | Synthesis of 6-Bromo-5-fluoroindole was carried out in this step according to the procedure reported by A. D. Batcho and W. Leimgruber; Org. Synth. 1985, 63, 214. A mixture of hydrazine hydrate (1.30 ml, 26.8 mmoles), crude [2-(4-Bromo-5-fluoro-2-nitro-phenyl)-vinyl]-dimethyl-amine as from step 2 and Raney nickle in tetrahydrofuran (30 ml) and methanol (30 ml) was stirred at room temperature over night. The catalyst was removed by filtration through celite and the filtrate was concentrated under reduced pressure. The residue was partitioned between ethyl acetate and 0.1N hydrogen chloride solution. The organic extract was washed with brine, dried (anhydrous sodium sulfate), and concentrated under reduced pressure. The residue was purified by flash column chromatography over silica gel eluding with 10percent ethyl acetate in hexane to give 6-Bromo-5-fluoro-1H-indole as a light green solid (0.865 g, 61percent). 1H NMR (CDCl3) d: 6.49-6.51 (m, 1H), 7.23-7.26 (m, 1H), 7.36 (d, 1H, J=9.2 Hz), 7.56 (dd, 1H, J=5.6 Hz, 0.9 Hz), 8.14 (bs, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
16% | With hydrazine hydrate In tetrahydrofuran; methanol; N,N-dimethyl-formamide | 6-Bromo-5-fluoroindole N,N-Dimethylformamide dimethylacetal (8.5 mL, 60 mmol) was added in one portion to a stirred solution of 3-bromo-4-fluoro-6-methylnitrobenzene (11.8 g, 50 mmol) in N,N-dimethylformamide (30 mL) at room temperature under Ar. The mixture was heated to 120° C., stirred for 16 h then concentrated in vacuo to leave a crude oil. The oil was crystallized [methanol-dichloromethane (4:1)] to give a purple solid (4.5 g). The solid was dissolved in methanol/tetrahydrofuran (1:1; 30 mL) and Raney Nickel.(R). (1 g) was added. The mixture was cooled to 0° C. and hydrazine hydrate (0.8 mL, 16 mmol) was added in one portion. The mixture was stirred at 0° C. for 90 min then a further aliquot of hydrazine hydrate (0.8 mL) was added. The mixture was stirred at 0° C. for 30 min then filtered through celite.(R). and the filter cake was washed with tetrahydrofuran. The filtrate was concentrated in vacuo and purified by column chromatography [SiO2; heptane-dichloromethane (4:1)] to give the product (1.7 g, 16percent) as an off-white solid: IR νmax (nujol)/cm-1 3395, 2925, 2855, 1570, 1469, 1451, 1408, 1314, 1145, 1105, 865, 763 and 502; NMR δH (400 MHz, CDCl3) 7.85 (1H, br. s), 7.55 (1H, d, J 5.5 Hz), 7.34 (1H, d, J 9 Hz), 7.23 (1H, t, J 2.8 Hz), 6.49-6.51 (1H, m). |
[ 627871-16-3 ]
5-Bromo-4-fluoro-2-methylaniline
Similarity: 0.86
[ 627871-16-3 ]
5-Bromo-4-fluoro-2-methylaniline
Similarity: 0.86